Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Mississippi.
Press releases published on October 7, 2025
La planta de fabricación de ZenaTech en Taiwán avanza a la fase de puesta en marcha y montaje de la línea de ensamblaje de componentes de drones compatibles con la NDAA para la defensa de EE. UU.
VANCOUVER, Columbia Británica, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones tecnológicas empresariales especializado en drones con inteligencia artificial (IA), Drones como un …
Geotab Ace, the Industry’s First Generative AI Assistant, Now Available to Fleets in Australia
SYDNEY, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Geotab Inc. (“Geotab”), the global leader in connected transportation solutions, today announced the official launch of Geotab Ace for all customers across Australia. Following its successful global debut, the …
Aduro Clean Technologies nimmt an der LD Micro Main Event XIX Conference teil
LONDON, Ontario, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Clean-Tech-Unternehmen, das die Kraft der Chemie nutzt, um geringwertige Einsatzstoffe wie …
Aduro Clean Technologies annonce sa participation à la conférence LD Micro Main Event XIX
LONDON, Ontario, 08 oct. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc., ci-après « Aduro » ou la « Société », (NASDAQ : ADUR) (CSE : ACT) (FSE : 9D5), une société de technologie propre qui recycle chimiquement les matières premières de moindre …
Rocket Doctor Provides Information on Annual General Meeting Proxy Circular
Vancouver, BC, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that, due to the Canada Postal Strike, there is a delay in the mailing of the Company’s proxy circular and related …
Quick Custom Intelligence Wins Prestigious G&L Transformation Award for Chatalytics – Their Fifth Win for Industry Innovation
SAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in AI-driven analytics and operational intelligence, announced that it has been awarded the Gaming …
CEA Industries (BNC) Appoints Seasoned Legal Executive Carly E. Howard as Non-Executive Director
Louisville, CO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC), (“BNC” or “the Company”), a growth-oriented company focused on managing the world’s largest corporate treasury of BNB, today announced the appointment of Carly E. Howard, …
reAlpha Completes Full Integration of Naamche Into Core Operations, Advancing “One reAlpha” Strategy
DUBLIN, Ohio, Oct. 07, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the full integration of Naamche, its previously acquired subsidiary, into the …
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners
CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that it …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Neurona Expands Investigation of NRTX-1001 Cell Therapy into Mesial Temporal Lobe Epilepsy (MTLE) without Mesial Temporal Sclerosis (MTS)
- First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications or adverse events reported to date - - Data from this non-MTS cohort, together with results from Neurona’s ongoing Phase 1/2 …
Astera Labs Announces Conference Call to Review Third Quarter 2025 Financial Results
SANTA CLARA, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will release its financial results for the third …
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Dayforce Introduces New Dayforce AI Agents to Accelerate How Work Gets Done
MINNEAPOLIS and TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the next generation of Dayforce AI Agents. Purpose-built to deliver …
Dayforce Expands Collaboration with Microsoft to Transform HCM Workflows With AI
MINNEAPOLIS and TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global leader that makes work life better, today announced an expansion of its collaboration with Microsoft to bring Dayforce AI Agents into everyday …
Dayforce Launches Strategic Workforce Planning
MINNEAPOLIS and TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the availability of Dayforce Strategic Workforce Planning to help …
Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025
Présentation d’une comparaison entre histologie numérique et sur lame des biopsies de screening de l’étude de Phase 3 NATiV3 Présentation de pathologie numérique de données précliniques avec lanifibranor Daix (France), New York City (New York, United …
Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025
Presentation of a comparison between digital and glass slide histology from screening biopsies in the Phase 3 NATiV3 study Presentation of digital pathology data from preclinical studies with lanifibranor Daix (France), New York City (New York, United …